Efficacy and safety of different oral prednisone tapering courses in adult anti‐ NMDAR encephalitis: A multicenter prospective cohort study
Epilepsia · 2024
DOI: 10.1111/epi.18107 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Epilepsia, 2024. Verfasst von Linjun Cai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Anti-N-Methyl-D-Aspartate Receptor Encephalitis, Prednisone. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Sichuan Province, National Key R&D Program of China.
Abstract (Originalsprache)
Objective
In adult anti‐ N ‐methyl‐ d ‐aspartate receptor (NMDAR) encephalitis, corticosteroids are commonly used as first‐line treatment. However, the optimal oral prednisone tapering (OPT) following intravenous methylprednisolone pulse therapy remains unclear. We aim to compare the efficacy and safety of different OPT courses in anti‐NMDAR encephalitis.
Methods
The CHASE study, a multicenter prospective observational cohort study, enrolled patients with autoimmune encephalitis from October 2011 to March 2023. Patients were grouped based on oral prednisone tapering course: ≤3 months (Group ≤3 month), 3–6 months (Group 3–6 months, including 3 months), and >6 months (Group > 6 months). Kaplan–Meier plots were used to analyze time to relapse and time to total recovery within 2 years.
Results
Among 666 screened patients, 171 (median [IQR] age 27 [21.0–36.5] years, 55.0% female) met selection criteria. Responders at 3 months were prevalent in Group ≤3 months (OR 7.251 [95% CI 2.252 to 23.344] and Group 3–6 months (OR, 3.857 [95% CI 1.107 to 13.440] than in Group >6 months. Clinical Assessment Scale for Autoimmune Encephalitis (CASE) scores at 12 months were higher in Group >6 months than in Group ≤3 months and Group 3–6 months ( β , −2.329 [95% CI −3.784 to −.875]; β , −2.871 [95% CI −4.490, −1.253]). CASE seizures subscore was higher in Group >6 months than in Group 3–6 months ( β , −.452 [95% CI −.788 to −.116]). No significant difference in seizure freedom rates among the groups. Adverse events were higher in Group 3–6 months and Group >6 months than in Group ≤3 months (OR 6.045 [95% CI 2.352 to 15.538]; OR 6.782 [95% CI 1.911 to 24.073]). Significance Longer oral prednisone courses for adult patients with anti‐NMDAR encephalitis did not show superior effects compared to shorter courses in improving modified Rankin Scale (mRS) scores and CASE scores, reducing the risk of relapse within 2 years, or achieving seizure freedom. Instead, extended prednisone courses may lead to more side effects— particularly weight gain. This outcome recommends evaluating the possibility of shortening the duration of oral prednisone after a thorough patient assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Institute of Brain Science and Brain-Inspired Technology of West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Neurology, West China Tianfu Hospital of Sichuan University, Chengdu, Sichuan, China.
- Department of Neurology, Chengdu Shangjin Nanfu Hospital, Chengdu, Sichuan, China.
Förderung
- China Postdoctoral Science Foundation
- Natural Science Foundation of Sichuan Province
- National Key R&D Program of China
- Clinical Research Incubation Project of West China Hospital of Sichuan University
- 1.3.5 project for disciplines of excellence and Brain Science project of West China Hospital, Sichuan University
- West China Nursing Discipline Development Special Fund Project, Sichuan University
- Postdoctoral Fellowship Program of CPSF
- National Natural Science Foundation of China
Zitieren
APA
Cai, L., Li, G., Abdulaziz, A. T., Gong, X., Liu, X., Kong, X., Guo, K., Li, A., Li, J., Zhou, D., & Hong, Z. (2024). Efficacy and safety of different oral prednisone tapering courses in adult anti‐ NMDAR encephalitis: A multicenter prospective cohort study. Epilepsia. https://doi.org/10.1111/epi.18107
Vancouver
Cai L, Li G, Abdulaziz AT, Gong X, Liu X, Kong X, et al. Efficacy and safety of different oral prednisone tapering courses in adult anti‐ NMDAR encephalitis: A multicenter prospective cohort study. Epilepsia. 2024. doi:10.1111/epi.18107
BibTeX
@article{Cai2024,
author = {Cai, Linjun and Li, Gaowei and Abdulaziz, Ammar T and Gong, Xue and Liu, Xu and Kong, Xueying and Guo, Kundian and Li, Aiqing and Li, Jinmei and Zhou, Dong and Hong, Zhen},
title = {Efficacy and safety of different oral prednisone tapering courses in adult anti‐ NMDAR encephalitis: A multicenter prospective cohort study},
journal = {Epilepsia},
year = {2024},
doi = {10.1111/epi.18107}
}
EUVIMED